In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Fisher Scientific terminates purchase of PSS World Medical

Executive Summary

Hoping to create a company with pro forma 2001 revenues of $4.8bn, life sciences and diagnostics supplier Fisher Scientific will buy medical equipment distributor PSS World Medical. The deal will involve the exchange of each of PSS's 71mm outstanding shares for .312 of its shares (paying $11.86 each--a (pr)24% premium). Based on Fisher's 10-day average pre-announcement price, the transaction is valued at $843mm, or just under half of PSS's fiscal 2000 revenues.
Deal Industry
  • Distributors
  • In Vitro Diagnostics
  • Medical Devices
  • Pharmaceuticals
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register